Avalyn Pharma’s $300M IPO: What Indian Investors Need to Know
Avalyn Pharma Inc.’s recent $300 million IPO has sent shockwaves in the pharmaceutical industry. Indian investors are keen to know more about this development and its potential impact on the market.